E
NBP

Ergoteles’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Ergoteles’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,500
Closed -$81.5K – 1479
2022
Q4 		$81.5K Buy
+19,500
New +$73.8K ﹤0.01% 1245

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ergoteles's NBP Position: Q1 2023 in Review

Ergoteles sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 19,500 shares — an estimated $81.5K sold.

Ergoteles first reported a position in NBP in Q4 2022 and held it in 1 quarter. The position peaked at $81.5K in Q4 2022. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

  • Ergoteles reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 19,500 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $81.5K.
  • Ergoteles first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Ergoteles's NovaBridge Biosciences American Depositary Shares position peaked at $81.5K in Q4 2022.
  • 53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.